Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
01 01 2022
01 01 2022
Historique:
received:
31
03
2021
accepted:
02
08
2021
pubmed:
15
9
2021
medline:
9
3
2022
entrez:
14
9
2021
Statut:
ppublish
Résumé
There are few studies testing the amount of weight loss necessary to achieve initial remission of type 2 diabetes mellitus (T2DM) following bariatric surgery and no published studies with use of weight loss to predict initial T2DM remission in sleeve gastrectomy (SG) patients. With Cox proportional hazards models we examined the relationship between initial T2DM remission and percent total weight loss (%TWL) after bariatric surgery. Categories of %TWL were included in the model as time-varying covariates. Of patients (N = 5,928), 73% were female; mean age was 49.8 ± 10.3 years and BMI 43.8 ± 6.92 kg/m2, and 57% had Roux-en-Y gastric bypass (RYGB). Over an average follow-up of 5.9 years, 71% of patients experienced initial remission of T2DM (mean time to remission 1.0 year). With 0-5% TWL used as the reference group in Cox proportional hazards models, patients were more likely to remit with each 5% increase in TWL until 20% TWL (hazard ratio range 1.97-2.92). When categories >25% TWL were examined, all patients had a likelihood of initial remission similar to that of 20-25% TWL. Patients who achieved >20% TWL were more likely to achieve initial T2DM remission than patients with 0-5% TWL, even if they were using insulin at the time of surgery. Weight loss after bariatric surgery is strongly associated with initial T2DM remission; however, above a threshold of 20% TWL, rates of initial T2DM remission did not increase substantially. Achieving this threshold is also associated with initial remission even in patients who traditionally experience lower rates of remission, such as patients taking insulin.
Identifiants
pubmed: 34518376
pii: dc21-0714
doi: 10.2337/dc21-0714
pmc: PMC8753771
doi:
Banques de données
figshare
['10.2337/figshare.15113349']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-99Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL130462
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 by the American Diabetes Association.
Références
Ann Surg. 2020 Feb;271(2):201-209
pubmed: 31425292
Health Technol Assess. 2011 Jan;15(2):1-182
pubmed: 21247515
Surg Obes Relat Dis. 2014 May-Jun;10(3):396-403
pubmed: 24951065
Int J Obes (Lond). 2021 Feb;45(2):396-403
pubmed: 32981929
JAMA. 2018 Oct 16;320(15):1560-1569
pubmed: 30326125
N Engl J Med. 2020 Aug 20;383(8):721-732
pubmed: 32813948
J Am Coll Surg. 2020 Jan;230(1):7-16
pubmed: 31672669
JAMA Surg. 2020 May 1;155(5):e200087
pubmed: 32129809
JAMA Surg. 2018 May 1;153(5):427-434
pubmed: 29214306
JAMA Surg. 2018 Jun 1;153(6):526-533
pubmed: 29450469
Br J Surg. 2021 Jan 27;108(1):49-57
pubmed: 33640917
Obes Surg. 2010 Oct;20(10):1385-92
pubmed: 20617465
JMIR Res Protoc. 2020 Apr 6;9(4):e14936
pubmed: 32249757
Am J Epidemiol. 2015 Jan 1;181(1):32-9
pubmed: 25515167
Med Care. 2009 Jun;47(6):626-33
pubmed: 19433995
Obes Surg. 2018 Jan;28(1):135-141
pubmed: 28695458
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
Obes Surg. 2021 May;31(5):2125-2135
pubmed: 33462670
N Engl J Med. 2017 Feb 16;376(7):641-651
pubmed: 28199805
Lancet Diabetes Endocrinol. 2014 Jan;2(1):12-3
pubmed: 24622660
JAMA. 2020 Sep 1;324(9):879-887
pubmed: 32870301
Obes Surg. 2020 May;30(5):1660-1670
pubmed: 31912466
Obes Surg. 2018 Aug;28(8):2297-2304
pubmed: 29484610
Am J Manag Care. 2004 Feb;10(2 Pt 2):163-70
pubmed: 15005509
Ann Intern Med. 2018 Dec 4;169(11):741-750
pubmed: 30383139
Obes Surg. 2014 May;24(5):727-34
pubmed: 24234735
Obes Surg. 2013 Jan;23(1):93-102
pubmed: 23161525
Diabetes Care. 2016 Aug;39(8):1400-7
pubmed: 27271192